233 related articles for article (PubMed ID: 22773753)
1. Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.
Shin J; Padmanabhan A; de Groh ED; Lee JS; Haidar S; Dahlberg S; Guo F; He S; Wolman MA; Granato M; Lawson ND; Wolfe SA; Kim SH; Solnica-Krezel L; Kanki JP; Ligon KL; Epstein JA; Look AT
Dis Model Mech; 2012 Nov; 5(6):881-94. PubMed ID: 22773753
[TBL] [Abstract][Full Text] [Related]
2. Mouse tumor model for neurofibromatosis type 1.
Vogel KS; Klesse LJ; Velasco-Miguel S; Meyers K; Rushing EJ; Parada LF
Science; 1999 Dec; 286(5447):2176-9. PubMed ID: 10591653
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Ecotropic Viral Integration Site 2B (EVI2B) Gene in Juvenile Myelomonocytic Leukemia and Neurofibromatosis Type 1 NF1 Tumors.
Saharafi P; Akar İ; Ersoy-Evans S; Anlar B; Varan A; Vargel I; Cetin M; Ayter S
Biochem Genet; 2024 Apr; 62(2):1263-1276. PubMed ID: 37584733
[TBL] [Abstract][Full Text] [Related]
4. p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs.
Grit JL; McGee LE; Tovar EA; Essenburg CJ; Wolfrum E; Beddows I; Williams K; Sheridan RTC; Schipper JL; Adams M; Arumugam M; Vander Woude T; Gurunathan S; Field JM; Wulfkuhle J; Petricoin EF; Graveel CR; Steensma MR
Oncogene; 2024 May; 43(19):1411-1430. PubMed ID: 38480916
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation in NF1 gene of patient with Neurofibromatosis type 1: A case report and functional study.
Zhang T; Jia C; Dong Z; Li C; Lu W
Mol Genet Genomic Med; 2021 May; 9(5):e1643. PubMed ID: 33764694
[TBL] [Abstract][Full Text] [Related]
6. Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.
Isakov O; Wallis D; Evans DG; Ben-Shachar S
EBioMedicine; 2018 Oct; 36():508-516. PubMed ID: 30274822
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.
Carroll SL
Acta Neuropathol; 2012 Mar; 123(3):321-48. PubMed ID: 22160322
[TBL] [Abstract][Full Text] [Related]
8. Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential.
Williams JP; Wu J; Johansson G; Rizvi TA; Miller SC; Geiger H; Malik P; Li W; Mukouyama YS; Cancelas JA; Ratner N
Cell Stem Cell; 2008 Dec; 3(6):658-69. PubMed ID: 19041782
[TBL] [Abstract][Full Text] [Related]
9. Translating current basic research into future therapies for neurofibromatosis type 1.
Brosseau JP; Liao CP; Le LQ
Br J Cancer; 2020 Jul; 123(2):178-186. PubMed ID: 32439933
[TBL] [Abstract][Full Text] [Related]
10. Perinatal or adult Nf1 inactivation using tamoxifen-inducible PlpCre each cause neurofibroma formation.
Mayes DA; Rizvi TA; Cancelas JA; Kolasinski NT; Ciraolo GM; Stemmer-Rachamimov AO; Ratner N
Cancer Res; 2011 Jul; 71(13):4675-85. PubMed ID: 21551249
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry.
Tabata MM; Li S; Knight P; Bakker A; Sarin KY
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814709
[TBL] [Abstract][Full Text] [Related]
12.
Atsoniou K; Giannopoulou E; Georganta EM; Skoulakis EMC
Cells; 2024 Apr; 13(8):. PubMed ID: 38667335
[TBL] [Abstract][Full Text] [Related]
13. Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.
Bajenaru ML; Zhu Y; Hedrick NM; Donahoe J; Parada LF; Gutmann DH
Mol Cell Biol; 2002 Jul; 22(14):5100-13. PubMed ID: 12077339
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous and Engineered Large Animal Models of Neurofibromatosis Type 1.
Osum SH; Watson AL; Largaespada DA
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669386
[TBL] [Abstract][Full Text] [Related]
15. yippee like 3 (ypel3) is a novel gene required for myelinating and perineurial glia development.
Blanco-Sánchez B; Clément A; Stednitz SJ; Kyle J; Peirce JL; McFadden M; Wegner J; Phillips JB; Macnamara E; Huang Y; Adams DR; Toro C; Gahl WA; Malicdan MCV; Tifft CJ; Zink EM; Bloodsworth KJ; Stratton KG; ; Koeller DM; Metz TO; Washbourne P; Westerfield M
PLoS Genet; 2020 Jun; 16(6):e1008841. PubMed ID: 32544203
[TBL] [Abstract][Full Text] [Related]
16. Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.
Osum SH; Oribamise EI; Corbière SMAS; Taisto M; Jubenville T; Coutts A; Kirstein MN; Fisher J; Moertel C; Du M; Bedwell D; Largaespada DA; Watson AL
Mol Ther Nucleic Acids; 2023 Sep; 33():227-239. PubMed ID: 37520682
[TBL] [Abstract][Full Text] [Related]
17. Increased noise as an effect of haploinsufficiency of the tumor-suppressor gene neurofibromatosis type 1 in vitro.
Kemkemer R; Schrank S; Vogel W; Gruler H; Kaufmann D
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13783-8. PubMed ID: 12368469
[TBL] [Abstract][Full Text] [Related]
18. Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.
Darle A; Mahiet T; Aubin D; Doyen M; El Kassar L; Parfait B; Lemaitre G; Baldeschi C; Allouche J; Holic N
Front Cell Dev Biol; 2024; 12():1359561. PubMed ID: 38481529
[TBL] [Abstract][Full Text] [Related]
19. Generation of a zebrafish neurofibromatosis model via inducible knockout of
Rajan ARD; Huang Y; Stundl J; Chu K; Irodi A; Yang Z; Applegate BE; Bronner ME
bioRxiv; 2024 Apr; ():. PubMed ID: 38712289
[TBL] [Abstract][Full Text] [Related]
20. Retroviral integration at the Epi1 locus cooperates with Nf1 gene loss in the progression to acute myeloid leukemia.
Blaydes SM; Kogan SC; Truong BT; Gilbert DJ; Jenkins NA; Copeland NG; Largaespada DA; Brannan CI
J Virol; 2001 Oct; 75(19):9427-34. PubMed ID: 11533205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
